Clinical Trial Update: Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications [NA]

View source ↗

Summary

A completed clinical trial evaluating how SomaSignal tests influence the selection of glucose-lowering medications in patients with Type 2 diabetes mellitus and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 2 Diabetes, Cardiovascular Diseases | NA | Status: COMPLETED